71 related articles for article (PubMed ID: 16398612)
21. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
22. Screening of scFv-displaying phages recognizing distinct extracellular domains of EGF receptor by target-guided proximity labeling method.
Chang C; Takayanagi A; Yoshida T; Shimizu N
J Immunol Methods; 2011 Sep; 372(1-2):127-36. PubMed ID: 21782821
[TBL] [Abstract][Full Text] [Related]
23. Use of phage display for the generation of human antibodies that neutralize factor IXa function.
Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097
[TBL] [Abstract][Full Text] [Related]
24. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.
Gilbertson RJ; Perry RH; Kelly PJ; Pearson AD; Lunec J
Cancer Res; 1997 Aug; 57(15):3272-80. PubMed ID: 9242460
[TBL] [Abstract][Full Text] [Related]
26. [Preparation of human phage antibodies specific for SSA/Ro antigen and its sequence analysis].
Li YJ; Peng JM; Zhang FC
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1904-8. PubMed ID: 15631804
[TBL] [Abstract][Full Text] [Related]
27. Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule.
Friedman M; Orlova A; Johansson E; Eriksson TL; Höidén-Guthenberg I; Tolmachev V; Nilsson FY; Ståhl S
J Mol Biol; 2008 Mar; 376(5):1388-402. PubMed ID: 18207161
[TBL] [Abstract][Full Text] [Related]
28. A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth.
Müller N; Hartmann C; Genssler S; Koch J; Kinner A; Grez M; Wels WS
Int J Cancer; 2014 Jun; 134(11):2547-59. PubMed ID: 24243620
[TBL] [Abstract][Full Text] [Related]
29. Antitumor efficacy of the scFv-based fusion protein and its enediyne-energized analogue directed against epidermal growth factor receptor.
Sheng W; Shang Y; Miao Q; Li Y; Zhen Y
Anticancer Drugs; 2012 Apr; 23(4):406-16. PubMed ID: 22205154
[TBL] [Abstract][Full Text] [Related]
30. Isolation of Lawsonia intracellularis specific single-chain Fv antibody fragments from phage display library.
Dezorzová-Tomanová K; Molinková D; Pekarová M; Celer V; Smola J
Res Vet Sci; 2007 Aug; 83(1):85-90. PubMed ID: 17198717
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the dimerization profiles of HER tyrosine kinases by time-resolved Förster resonance energy transfer (TR-FRET).
Lopez-Crapez E; Ho-Pun-Cheung A; Garnero P; Bazin H
Methods Mol Biol; 2015; 1233():45-55. PubMed ID: 25319888
[TBL] [Abstract][Full Text] [Related]
32. Selection of tumor-specific internalizing human antibodies from phage libraries.
Poul MA; Becerril B; Nielsen UB; Morisson P; Marks JD
J Mol Biol; 2000 Sep; 301(5):1149-61. PubMed ID: 10966812
[TBL] [Abstract][Full Text] [Related]
33. Mammalian Expression and
Grindel BJ; Engel BJ; Hall CG; Kelderhouse LE; Lucci A; Zacharias NM; Takahashi TT; Millward SW
ACS Omega; 2020 Oct; 5(39):25440-25455. PubMed ID: 33043224
[TBL] [Abstract][Full Text] [Related]
34. An engineering strategy to target activated EGFR with CAR T cells.
Dobersberger M; Sumesgutner D; Zajc CU; Salzer B; Laurent E; Emminger D; Sylvander E; Lehner E; Teufl M; Seigner J; Bobbili MR; Kunert R; Lehner M; Traxlmayr MW
Cell Rep Methods; 2024 Apr; 4(4):100728. PubMed ID: 38492569
[TBL] [Abstract][Full Text] [Related]
35. Magnetic Bead-Immobilized Mammalian Cells Are Effective Targets to Enrich Ligand-Displaying Yeast.
Lown PS; Hackel BJ
ACS Comb Sci; 2020 May; 22(5):274-284. PubMed ID: 32283920
[TBL] [Abstract][Full Text] [Related]
36. Ligand Engineering via Yeast Surface Display and Adherent Cell Panning.
Stern LA; Lown PS; Hackel BJ
Methods Mol Biol; 2020; 2070():303-320. PubMed ID: 31625103
[TBL] [Abstract][Full Text] [Related]
37. Cellular-Based Selections Aid Yeast-Display Discovery of Genuine Cell-Binding Ligands: Targeting Oncology Vascular Biomarker CD276.
Stern LA; Lown PS; Kobe AC; Abou-Elkacem L; Willmann JK; Hackel BJ
ACS Comb Sci; 2019 Mar; 21(3):207-222. PubMed ID: 30620189
[TBL] [Abstract][Full Text] [Related]
38. A semi high-throughput method for screening small bispecific antibodies with high cytotoxicity.
Sugiyama A; Umetsu M; Nakazawa H; Niide T; Onodera T; Hosokawa K; Hattori S; Asano R; Kumagai I
Sci Rep; 2017 Jun; 7(1):2862. PubMed ID: 28588218
[TBL] [Abstract][Full Text] [Related]
39. Optical imaging probes in oncology.
Martelli C; Lo Dico A; Diceglie C; Lucignani G; Ottobrini L
Oncotarget; 2016 Jul; 7(30):48753-48787. PubMed ID: 27145373
[TBL] [Abstract][Full Text] [Related]
40. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.
Lehmann A; Wixted JH; Shapovalov MV; Roder H; Dunbrack RL; Robinson MK
MAbs; 2015; 7(6):1058-71. PubMed ID: 26337947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
